Squarepoint’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$66.3K Buy
+32,572
New +$66.3K ﹤0.01% 2569
2025
Q1
Sell
-51,255
Closed -$93.8K 2991
2024
Q4
$93.8K Sell
51,255
-273
-0.5% -$500 ﹤0.01% 2549
2024
Q3
$298K Buy
+51,528
New +$298K ﹤0.01% 2002
2024
Q2
Sell
-21,721
Closed -$301K 2728
2024
Q1
$301K Buy
+21,721
New +$301K ﹤0.01% 1918
2023
Q3
Sell
-1,734
Closed -$9.29K 2653
2023
Q2
$9.29K Buy
+1,734
New +$9.29K ﹤0.01% 2345
2022
Q3
Sell
-4,051
Closed -$84K 2280
2022
Q2
$84K Buy
+4,051
New +$84K ﹤0.01% 1898
2021
Q4
Sell
-2,286
Closed -$196K 2656
2021
Q3
$196K Sell
2,286
-4,784
-68% -$410K ﹤0.01% 1834
2021
Q2
$786K Buy
+7,070
New +$786K ﹤0.01% 1339
2021
Q1
Sell
-6,910
Closed -$734K 2778
2020
Q4
$734K Buy
6,910
+4,527
+190% +$481K 0.01% 1244
2020
Q3
$332K Sell
2,383
-292
-11% -$40.7K ﹤0.01% 1616
2020
Q2
$865K Sell
2,675
-226
-8% -$73.1K 0.01% 1014
2020
Q1
$259K Buy
+2,901
New +$259K 0.01% 1359
2019
Q3
Sell
-2,865
Closed -$101K 2379
2019
Q2
$101K Buy
2,865
+1,636
+133% +$57.7K ﹤0.01% 2154
2019
Q1
$55K Sell
1,229
-1,022
-45% -$45.7K ﹤0.01% 2026
2018
Q4
$108K Buy
2,251
+861
+62% +$41.3K ﹤0.01% 1775
2018
Q3
$93K Sell
1,390
-10,701
-89% -$716K ﹤0.01% 1885
2018
Q2
$569K Buy
+12,091
New +$569K 0.01% 1132
2018
Q1
Sell
-6,454
Closed -$320K 1896
2017
Q4
$320K Buy
+6,454
New +$320K 0.01% 1448
2017
Q2
Sell
-1,556
Closed -$124K 1649
2017
Q1
$124K Sell
1,556
-1,596
-51% -$127K ﹤0.01% 1374
2016
Q4
$262K Buy
3,152
+1,644
+109% +$137K 0.01% 1234
2016
Q3
$169K Buy
+1,508
New +$169K 0.01% 917
2016
Q1
Sell
-5,050
Closed -$407K 1300
2015
Q4
$407K Buy
5,050
+4,125
+446% +$332K 0.04% 646
2015
Q3
$64K Buy
+925
New +$64K 0.02% 383